Back to VICTORY CAPITAL MANAGEMENT INC VICTORY CAPITAL MANAGEMENT INC

VIVOVIVO

Showing 0 of 18 quarters

Position history for VICTORY CAPITAL MANAGEMENT INCVICTORY CAPITAL MANAGEMENT INC's holdings in MERIDIAN BIOSCIENCE INC

As of its Q4 2022 13F, Victory Capital Management held 26,441 shares of VIVO (Meridian Bioscience), worth $878,106. Victory Capital Management's 13F filings listed VIVO from Q4 2018 to Q4 2022, 17 quarterly filings.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

0

No position history available for this security.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used